Literature DB >> 29133938

Prostate cancer: Response prediction with HSD3B1.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29133938     DOI： 10.1038/nrurol.2017.192

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer.

Authors:  Nima Almassi; Chad Reichard; Jianbo Li; Carly Russell; Jaselle Perry; Charles J Ryan; Terence Friedlander; Nima Sharifi
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

2.  Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.

Authors:  Jason W D Hearn; Wanling Xie; Mari Nakabayashi; Nima Almassi; Chad A Reichard; Mark Pomerantz; Philip W Kantoff; Nima Sharifi
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.